SEC Tracker
Get the app

Possible new ACTU shares

ACTUDilution

Last raise Oct 28, 2026, 424B5: 31.0M shares (129.0% of the 24.0M then)

Known so far: no new shares from the prospectus covers read · shelf room about $14.0M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $14.0M, maybe lower
  • One third of float $14.0M ($42.1M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $14.0M on the S-3 of Sep 2, 2025: the baby-shelf rule (public float under $75M) caps sales at one third of the $42.1M public float stated as of Jun 30, 2025, $14.0M, nothing sold off it in the last 12 months; 1 more sale off the shelf with no size read, so the room may be lower. Sources: S-3 Sep 2, 2025, effective Sep 8, 2025 · public float, as of Jun 30, 2025 · 424B5 Nov 28, 2025.

What could become new Actuate Therapeutics (ACTU) shares, from its 10-Q, 10-K, S-1 or 424B filings.

Read so far: the cover share count (24M shares, +16% from 20.7M on Aug 13, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-1 registration filings.

Shares outstanding

24.0M

Nov 2024 to Aug 2026: from 19.5M to 24.0M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.